A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease "EUCLID"


Phase 3 Results

Eligibility Criteria

Inclusion Criteria

- Male and Female patients 50 years old or older Symptomatic peripheral artery disease

Exclusion Criteria

- Patients needing dual anti-platlet drug treatment before start of study Planned revascularisation or amputation
- Patients with known bleeding disorders
- Patients with a history of intracranial bleed
- Patients considered to be at risk of bradycardic events unless already treated with a permanent pacemaker